Sanofi Canada joins Anaphylaxis Canada's Corporate Partner Program
We are pleased to announce that Sanofi Canada (Sanofi) has joined our Corporate Partners Program. The aim of this program is to help companies understand and respond to the needs of allergic consumers.
Sanofi has just announced the launch of Allerject ™, their new epinephrine auto-injector, which is now available in some pharmacies.
To view their press release, please click here: http://www.newswire.ca/en/story/1104405/allerjecttm-canada-s-first-talking-epinephrine-auto-injector
To learn more about Allerject ™ , visit their website at www.allerject.ca where you will find information and an instructional video.
Anaphylaxis Canada would like to thank Sanofi for their support through our Corporate Partners Program.
From the Anaphylaxis Canada Team
Return to Hot topics